In addition, recent studies have shown that deletion of arginase 2 ameliorates high-fat induced obesity and the associated nonalcoholic fatty liver disease (NAFLD) [11,12]. Here, ARG2 is linked to metabolic dysfunction-associated steatotic liver disease.